Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | CCR4 | P51679 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | PDE5A | O76074 | 1/20 | 0.35 |
| ▸ | GCK | P35557 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL8059245 | 0.92 | SMN1; SMN2 (0.45) | SMN1; SMN2KMT2AGAAMEN1PDE5A | |
| SCHEMBL9050304 | 0.81 | SMN1; SMN2 (0.56) | SMN1; SMN2KMT2AGAAMEN1PDE5A | |
| SCHEMBL2448139 | 0.79 | SCD (0.39) | SMN1; SMN2KMT2AMEN1ALDH1A1MAPT | |
| SCHEMBL8982570 | 0.79 | KMT2A (0.35) | SMN1; SMN2KMT2AGAAMEN1PDE5A | |
| SCHEMBL5685884 | 0.79 | SMN1; SMN2 (0.38) | SMN1; SMN2KMT2AGAAMEN1LMNA | |
| SCHEMBL5213000 | 0.77 | GABRA5 (0.53) | SMN1; SMN2KMT2AGAAMEN1PDE5A | |
| SCHEMBL10134063 | 0.77 | ALDH1A1 (0.58) | SMN1; SMN2KMT2AGAAMEN1LMNA | |
| SCHEMBL12824136 | 0.77 | GCK (0.43) | SMN1; SMN2KMT2AGAAMEN1GCK | |
| SCHEMBL676084 | 0.77 | SMN1; SMN2 (0.64) | SMN1; SMN2KMT2AGAAMEN1LMNA | |
| SCHEMBL2612386 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129415-B2 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | BAYER CROPSCIENCE AG (DE) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192196-A1 | Fungicide hydroximoyl-tetrazole derivatives | HAAO, HAO1, CYP51A1 | SMN1; SMN2 4339/4885KMT2A 609/4885GAA 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.